Table 1

Characteristics of patients in the study cohort

VariableAll patients (n=37 120)LDL-C ≤1.8 mmol/L (n=6747)LDL-C >1.8 mmol/L (n=30 373)
Age73.0 (10.1)73.2 (9.9)73.0 (10.1)
Sex (female)13 585 (36.6%)1897 (28.1%)11 688 (38.5%)
Smoking*4221 (12.7%)755 (12.3%)3466 (12.7%)
SBP (mm Hg)132.8 (16.1)130.6 (15.6)133.3 (16.2)
DBP (mm Hg)75.3 (10.7)73.9 (10.7)75.6 (10.7)
Total cholesterol (mmol/L)*4.5 (1.2)3.4 (0.7)4.8 (1.1)
LDL-C (mmol/L)2.7 (1.0)1.5 (0.3)3.0 (0.9)
Triglyceride (mmol/L)*1.6 (0.9)1.5 (1.0)1.6 (0.9)
Hypertension30 869 (83.2%)5649 (83.7%)25 220 (83.0%)
Diabetes12 544 (33.8%)3116 (46.2%)9428 (31.0%)
CHD37 120 (100.0%)6747 (100.0%)30 373 (100.0%)
AMI16 742 (45.1%)3740 (55.4%)13 002 (42.8%)
AMI past year1544 (4.2%)441 (6.5%)1103 (3.6%)
Stroke4452 (12.0%)921 (13.7%)3531 (11.6%)
Stroke past year1292 (3.5%)266 (3.9%)1026 (3.4%)
CVD19 183 (51.7%)4177 (61.9%)15 006 (49.4%)
Heart failure8888 (23.9%)1951 (28.9%)6937 (22.8%)
Atrial fibrillation8257 (22.2%)1807 (26.8%)6450 (21.2%)
Dementia1363 (3.7%)224 (3.3%)1139 (3.8%)
ASA23 431 (63.1%)4426 (65.6%)19 005 (62.6%)
Statin25 160 (67.8%)5735 (85.0%)19 425 (64.0%)
Simvastatin12 820 (34.5%)2810 (41.6%)10 010 (33.0%)
Pravastatin286 (0.8%)20 (0.3%)266 (0.9%)
Atorvastatin11 424 (30.8%)2723 (40.4%)8701 (28.6%)
Rosuvastatin998 (2.7%)235 (3.5%)763 (2.5%)
Other lipid-lowering drugs1231 (3.3%)227 (3.4%)1004 (3.3%)
Ezetimib953 (2.6%)175 (2.6%)778 (2.6%)
  • Mean (SD) and frequencies (%).

  • *Missing data: smoking 3753, SBP 616, DBP 625, Total cholesterol 1510, Triglyceride 5366. For other variables there is no missing data.

  • AMI, acute myocardial infarction; ASA, acetylic salicylic acid; CHD, coronary heart disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure.